IntegraGen's mission is to translate molecular data into actionable information by providing cutting-edge genomic services and bioinformatic tools to clinicians, researchers and life sciences companies. IntegraGen is listed on Alternext of Euronext Paris (ISIN: FR0010908723 - Ticker: ALINT - PEA-SME).